Cartesian Therapeutics
RNAC
RNAC
59 hedge funds and large institutions have $105M invested in Cartesian Therapeutics in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
-4
Holders Change %
-6.35%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
17
Reduced
23
Closed
12
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$2K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$1.79M |
| 2 |
AG
Artal Group
Luxembourg
|
+$1.27M |
| 3 |
SRF
Silver Rock Financial
Los Angeles,
California
|
+$693K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$509K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$421K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$2.8M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.24M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$1.94M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.75M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$982K |
